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Background: The prevalence of diabetes is alarmingly high among Mexican American adults residing near the
U.S.-Mexico border. Depression is also common among Mexican Americans with diabetes, and may have a negative
influence on diabetes management. Thus, the purpose of the current study was to evaluate the associations of
depression and anxiety with the behavioral management of diabetes and glycemic control among Mexican
American adults living near the border.
Methods: The characteristics of Mexican Americans with diabetes living in Brownsville, TX (N = 492) were compared
by depression/anxiety status. Linear regression models were conducted to evaluate the associations of depression
and anxiety with BMI, waist circumference, physical activity, fasting glucose, and glycated hemoglobin (HbA1c).
Results: Participants with clinically significant depression and/or anxiety were of greater age, predominantly female,
less educated, more likely to have been diagnosed with diabetes, and more likely to be taking diabetes
medications than those without depression or anxiety. In addition, anxious participants were more likely than those
without anxiety to have been born in Mexico and to prefer study assessments in Spanish rather than English.
Greater depression and anxiety were associated with poorer behavioral management of diabetes (i.e., greater BMI
and waist circumference; engaging in less physical activity) and poorer glycemic control (i.e., higher fasting glucose,
HbA1c).
Conclusions: Overall, depression and anxiety appear to be linked with poorer behavioral management of diabetes
and glycemic control. Findings highlight the need for comprehensive interventions along the border which target
depression and anxiety in conjunction with diabetes management.Background
Diabetes is a leading public health concern of particular
relevance to Mexican Americans. Between 2003–2006,
the estimated age-adjusted prevalence of diabetes among
Mexican Americans adults ≥ 20 years of age was 16.3%,
compared with 9% among non-Hispanic Whites [1]. More-
over, the prevalence of diabetes was recently estimated to
be over 30% among Mexican American adults residing near
the U.S.-Mexico border [2]. Overweight/obesity prevalence* Correspondence: Darla.Kendzor@UTSouthwestern.edu
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reproduction in any medium, provided the oris also alarmingly high among Mexican Americans at
81.2%, compared with 66.7% among non-Hispanic Whites
[3]. Numerous studies have shown that obesity and weight
gain are linked with the onset of diabetes [4-6]. Unfortu-
nately, Mexican Americans with diabetes, particularly
those born in the U.S., are at greater risk of all-cause mor-
tality than non-Hispanic Whites [7]. In order to address
diabetes-related health disparities, focused research will be
needed to better understand the physiological, psycho-
social, and behavioral factors that contribute to the onset
and course of diabetes among Mexican Americans.
Research indicates that the relationship between de-
pression and diabetes is bi-directional [8-13]. Depression
is associated with the development of diabetes [8,12]. Con-
versely, diabetes is associated with the development ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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depression, it is not surprising that higher rates of depres-
sion are found among diabetic patients in cross-sectional
studies. Further, Mexican Americans with diabetes are
more likely than other racial/ethnic groups to report
symptoms of depression [14]. In fact, rates of clinically
significant depressive symptoms have been reported to
be as high as 40% among individuals of Mexican origin
with diabetes who live on either side of the South Texas
border [15]. The presence of depression in diabetes is
noteworthy because depression may influence glycemic
control among individuals with diabetes through physio-
logical and behavioral pathways (for reviews, see [16-19]).
Less is known about how anxiety might influence gly-
cemic control. Initial research suggests that adults with
diabetes may have elevated levels of anxiety and greater
anxiety disorder prevalence relative to the general
population [20-23]. Higher levels of anxiety have also
been reported among Mexicans with diabetes [24].
However, initial findings related to the impact of anxiety
on glycemic control among individuals with diabetes
are equivocal [20,25,26]. In a meta-analysis, Anderson
et al. [25] reported that the relationship between anxiety
and glycemic control only approached significance,
though anxiety measured via diagnostic interviews was
significantly associated with hyperglycemia. Since then,
Gois et al. [26] reported that anxiety (measured via self-
report questionnaire) was not associated with glycemic
control (i.e., HbA1c < 8 or ≥ 8). Conversely, Collins et al.
[20] reported that having a high level of anxiety (mea-
sured via self-report questionnaire) was associated with
poor perceived glycemic control and a greater number
of diabetes complications. As such, research is needed
to clarify the relations between anxiety and glycemic con-
trol in general and specifically among Latinos/Hispanics
with diabetes.
Depression is associated with hyperglycemia and ele-
vated HbA1c levels among individuals with diabetes
[27-31]. Behavioral factors that contribute to poor
glycemic control among individuals with diabetes may
include poor adherence to recommended health behav-
iors including diet, weight control, physical activity, glu-
cose monitoring, and medication regimens [17,29,32-34].
McKellar et al. [35] reported that depression had a
negative impact on glucose regulation through self-care
behaviors including poor adherence to diabetes dietary
guidelines and poor medication adherence. Similarly,
Chiu et al. [31] reported that depressive symptoms nega-
tively influenced glycated hemoglobin (HbA1c) through
diabetes-related behavioral factors including inadequate
physical activity and greater body mass index (BMI). Re-
cently, the link between depression and elevated HbA1c
has been demonstrated specifically among Latinos/
Hispanics with diabetes [36]. Plausibly, the samebehavioral factors may be influenced by anxiety among
individuals with diabetes. Additional research is needed to
characterize the relations of depression and anxiety with
the behavioral management of diabetes and glycemic con-
trol among Latinos/Hispanics.
The primary purpose of the current study was to
evaluate the cross-sectional associations of depression
and anxiety with modifiable factors known to influence
glycemic control (i.e., BMI, waist circumference, and phys-
ical activity) and more direct measures of glycemic control
(i.e., HbAlc and fasting glucose) among Mexican Americans
with diabetes residing near the Texas-Mexico border.
Potential moderators of the associations of depression
and anxiety with diabetes-related factors were also evalu-
ated including age, gender, education, preferred language,
and birth country.
Subjects
Participants were recruited from randomly selected house-
holds and invited to participate in the Cameron County
Hispanic Cohort (CCHC; see [37]). Participants included
in the current analyses were 492 adults ≥ 18 years of age
living in the Brownsville, Texas metropolitan area on the
Texas-Mexico border. The overarching CCHC design and
methodology have been described elsewhere [37]. A subset
of all participants with diabetes were selected for the
current analyses who were born either in Mexico or the
U.S. Consistent with the American Diabetes Association
definition of diabetes [38], participants were included in
the current study if they met one or more of the follow-
ing criteria: 1) told by a doctor that he/she has diabetes,
2) currently taking a medication to manage diabetes,
3) fasting glucose ≥ 126 mg/dl, and/or 4) HbA1c ≥ 6.5.
The study protocol was approved by the Committee
for the Protection of Human Subjects at the University
of Texas Health Science Center (HSC-SPH-03-007-B),




Socioeconomic and demographic characteristics assessed
included age (in years), gender, years of education, birth
country (Mexico or U.S.), and preferred language of study
assessments (Spanish or English).
Depression/anxiety
The Center for Epidemiological Studies Depression (CES-D)
questionnaire is a 20-item self-report measure of depres-
sive symptoms over the past week [39]. Items are rated on
a 4-point scale, and total scores may range from 0 to 60.
Scores ≥ 16 indicate clinically significant distress (will be
referred to as depression throughout the manuscript). The
Zung Self-Rating Anxiety Scale (SAS) is a 20-item self-
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point scale, and total scores may range from 20–80 with
scores from 20–44 considered to be in the normal range.
Higher scores are suggestive of greater anxiety.
Anthropometric characteristics
BMI was calculated based on weight and height mea-
surements (kg/m2). Weight was measured without shoes
to the nearest 0.2 kg using a portable electronic scale,
and height was measured to the nearest 0.2 cm using a
stadiometer. Waist circumference was measured with
the participant in a standing position, at the level of the
umbilicus to the nearest 0.2 cm.
Physical activity
Intensity and duration of physical activity during the last
7 days was assessed using validated instrumentation of
either the International Physical Activity Questionnaire
(IPAQ) [41,42] or the Godin Leisure-Time Exercise
Questionnaire [43,44]. While the physical activity ques-
tionnaire changed in response to broader study design
modifications, both measures assess moderate and vigor-
ous physical activity and allow for the calculation of
metabolic equivalent values (METS) using instrument-
specific scoring recommendations [45,46]. METs were
used as a continuous variable in the analysis. Partici-
pants who reported > 600 MET adjusted minutes in the
7 day period were considered to have met national phys-
ical activity guidelines [47]. The physical activity assess-
ment of some participants (n = 92) was not concurrent
with the other measures (i.e., was not completed on the
same date), and instead occurred during a later partici-
pant visit. However, additional analyses controlling for
the physical activity assessment (IPAQ vs. Godin vs. de-
layed assessment) did not substantially change the results
of the physical activity models.
Glycemic control
Fasting glucose (mg/dl) was measured using a Glucostat
Analyzer (Model 27, YSI, Inc. Yellow Springs, Ohio) follow-
ing a 10-hour overnight fast. Glycosylated hemoglobin was
measured on frozen whole blood using the GLYCO-Tek®
Affinity column method Helena Laboratories, Beaumont,
TX; [48] or by High Performance Liquid Chromatography.
The validity of affinity chromatography for the determin-
ation of glycosylated hemoglobin has been demonstrated
in comparison with other methods [49].
Statistical analyses
Cross-sectional associations of depression and anxiety
with BMI, waist circumference, physical activity, fasting
glucose, and HbA1c were examined among Mexican
Americans with diabetes in a series of linear regression
models. Scatter plots of predicted values by residualswere examined to evaluate and confirm linearity. Be-
cause of the complex survey design, models accounted
for socioeconomic stratum, census tract and block, and
gender (for details, see [37]). Covariates included age,
gender, years of education, language of study assessment
(Spanish or English), and birth country (Mexico or U.S.).
Current diabetes medication use (yes or no) was included
as a covariate in the models where fasting glucose or
HbA1c were the outcome variables. Interactions between
study covariates with depression and/or anxiety were ex-
amined to determine whether any of the variables func-
tioned as moderators of the relations between depression/
anxiety and diabetes-related outcomes (i.e., BMI, waist cir-
cumference, physical activity, fasting glucose, and HbA1c).
Interaction terms were created by multiplying depression
and anxiety with each of the covariates. Interactions
terms were evaluated for significance by including them
individually in a linear regression model along with ei-
ther depression or anxiety and all covariates. When an
interaction term was found to be significant, the relation-
ship between depression or anxiety with diabetes-related
outcomes were further examined within either the natural
groupings of the moderating variable (i.e., gender, assess-
ment language, birth country) or the groups created by




Participant characteristics are presented in Table 1. In
summary, over 65% of participants were female, and most
had less than a high school education, were born in Mexico,
and elected to respond to questionnaires in Spanish rather
than English. In addition, most participants were obese and
appeared to have uncontrolled diabetes based on glycemic
control indicators (see also [2]). Participant characteristics
are presented by depression and anxiety status in Table 2.
Specifically, chi-square analyses and t-tests indicated that
those who experienced significant depressive symptoms
within the previous week (CES-D ≥ 16) were of significantly
greater age, were more likely to be female, had less edu-
cation, had higher BMI and greater waist circumference,
and reported less physical activity. They were also more
likely to have been previously diagnosed with diabetes
and to report taking diabetes medications. Similarly,
participants who exhibited greater anxiety (SAS ≥ 45)
were of significantly greater age, more likely to be fe-
male, had less education, were more likely to have been
born in Mexico, and to have completed study assess-
ments in Spanish. In addition, anxious participants had
greater BMI and waist circumference and were less
likely to meet physical activity guidelines. They were
also more likely to have been previously diagnosed with
diabetes and to report taking diabetes medications.
Table 1 Participant characteristics
N Mean (SD) % Range
Age (years) 492 51.3 (14.6) - 18-90
Gender (% Female) 492 - 65.2 -
Education (years) 492 9.1 (5.2) - 0-24
Birth Country (% Mexico) 492 - 66.5 -
Assessment Language (% Spanish) 492 - 78.0 -
BMI 488 33.2 (7.8) - 18.3-84.7
BMI ≥ 30 (% Obese) 488 - 65.8 -
Waist Circumference (cm) 491 108.0 (16.9) - 68-177
Physical Activity
(Metabolic Equivalents)
408 921.1 (3003.3) - 0-28,800
Not Meeting Physical Activity
Guidelines (%)
408 - 76.2 -
Told by a doctor that you
have Diabetes? (% yes)
492 - 57.7 -
Taking any medications
for Diabetes? (% yes)
492 - 50.8 -
Fasting Plasma Glucose (mg/dl) 492 155.0 (70.2) - 42-465
HbA1c 384 8.2 (2.3) - 4.6-17.7
HbA1c ≥ 6.5 (%) 384 - 85.7 -
CES-D Total Score 486 13.0 (12.3) - 0-54
CES-D Total Score ≥ 16
(% Depressed)
486 - 29.0 -
SAS Total Score 486 40.5 (8.7) - 21-74
SAS Total Score ≥ 45
(% Mild to Extreme Anxiety)
486 - 25.5 -
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After controlling for covariates (i.e., age, gender, years of
education, assessment language, birth country), linear re-
gression analyses correcting for design effects indicated
that depression (as measured by the CES-D) was signifi-
cantly and positively associated with BMI, p = .054
(model R2 = .03) and waist circumference, p = .005
(model R2 = .06), and negatively associated with physical
activity (METs), p = .007 (model R2 = .03; additional
analyses indicated that results remained significant even
after controlling for physical activity measure). Depres-
sion was also significantly and positively associated with
fasting glucose, p = .007 (model R2 = .13; see Table 3),
after controlling for all previously mentioned covariates
as well as medication status. Analyses indicated good fit
for each model (all p’s < .05). Depression was not signifi-
cantly associated with HbA1c.
Anxiety, modifiable factors, and glycemic control
After controlling for covariates (i.e., age, gender, educa-
tion, assessment language, birth country), linear regres-
sion analyses correcting for design effects indicated that
anxiety (as measured by the SAS) was positivelyassociated with BMI, p = .001 (model R2 = .04) and waist
circumference, p < .001 (model R2 = .08), and negatively
associated with physical activity (METs), p = .049
(model R2 = .03; additional analyses indicated that results
remained significant even after controlling for physical ac-
tivity measure). Similarly, anxiety was positively associated
with HbA1c, p = .047 (model R2 = .07), after for controlling
for all previously mentioned covariates and medication
status (see Table 4). Analyses indicated good fit for each
model (all p’s < .05). Anxiety was not significantly associ-
ated with fasting glucose.Moderation analyses
The interaction effects of age, gender, years of education,
assessment language, and birth country with depression
and anxiety on all diabetes related outcomes were eval-
uated (i.e., BMI, waist circumference, physical activity,
fasting glucose, and HbA1c). Age, years of education,
assessment language, and birth country were found to
function as moderators as described below. Gender was
not found to interact with depression or anxiety to pre-
dict modifiable factors related to diabetes management
or glycemic control.Interactions with depression
After controlling for all relevant covariates, there was a
significant interaction effect between depression and age
on fasting glucose, B = −.040; p = .042. Specifically, for
younger participants (< 52 years; median = 52 years of age)
greater depression was associated with higher fasting glu-
cose, while no association was found among participants
of greater age (52+ years). Results also revealed a signifi-
cant interaction between depression and education on
HbA1c, B = .004; p = .004. Among more educated partici-
pants (8+ years; median = 8 years of education), depression
was positively associated with HbA1c. No association was
found between depression and HbA1c among less edu-
cated participants (< 8 years). Depression interacted sig-
nificantly with language of assessment to predict HbA1c,
B = −.004; p = .054. For those who completed the assess-
ment in English, greater depression was associated with
higher HbA1c. No association between depression and
HbA1c was found among those who completed the as-
sessment in Spanish. Similarly, results revealed a signifi-
cant interaction between depression and birth country
to predict HbA1c, B = −.052; p = .013. Among those
born in the U.S., greater depression was associated with
higher HbA1c. No association between depression and
birth country was found among those born in Mexico.
Please note that birth country (U.S. vs. Mexico) was
highly correlated with preferred assessment language
(English vs. Spanish; r = .622, p < .001).
Table 2 Characteristics of Mexican Americans with diabetes by depression and anxiety status
Center for Epidemiologic Studies-Depression
(CES-D)
Zung Self-Rated Anxiety Scale (SAS)
Non-depressed
(score < 16; n = 345)
Depressed
(score ≥ 16; n = 141)
p Non-anxious
(score < 45; n = 362)
Anxious
(Score ≥ 45; n = 124)
p
Age (years) 49.79 (14.66) 55.10 (13.97) <.001 50.15 (14.69) 54.97 (13.80) .001
Gender (% female) 59.7 77.3 <.001 61.3 76.6 .002
Education (years) 9.62 (5.13) 7.96 (5.24) .001 9.54 (5.27) 7.90 (4.88) .002
Birth Country (% Mexico) 64.6 70.2 .238 63.8 73.4 .052
Assessment Language (% Spanish) 76.5 81.6 .224 75.1 86.3 .010
BMI 32.73 (7.58) 34.44 (8.17) .029 32.50 (6.99) 35.45 (9.41) <.001
BMI ≥ 30 (% obese) 63.2 72.1 .059 64.9 69.1 .396
Waist Circumference (cm) 106.86 (16.69) 111.12 (17.17) .012 106.40 (15.65) 113.19 (19.31) <.001
Physical Activity (Metabolic Equivalents) 1124.91 (3470.5) 361.0 (961.0) .023 1061.6 (3145.2) 502.4 (2583.5) .101
Not Meeting Physical Activity Guidelines (%) 74.7 81.1 .175 72.1 88.7 .001
Told by a doctor that you have Diabetes?
(% yes)
52.2 71.6 <.001 52.8 72.6 <.001
Taking any medications for Diabetes? (% yes) 47.0 60.3 .008 45.9 65.3 <.001
Fasting Plasma Glucose (mg/dl) 151.86 (67.57) 162.48 (75.04) .129 151.74 (67.23) 164.40 (76.62) .082
HbA1c 8.2 (2.3) 8.3 (2.5) .684 8.1 (2.3) 8.5 (2.5) .118
HbA1c ≥ 6.5 (%) 86.5 83.2 .407 85.2 86.7 .733
Note: Means (standard deviations) are presented unless otherwise specified. The number of participants represented in each row may be lower than the numbers
indicated at the top of column when there are missing data for the specific variable.
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Results indicated a significant interaction between anx-
iety and age, B = 1.630; p = .005, such that anxiety was
inversely associated with physical activity (METs) among
participants of younger age (< 52 years; median = 52 years
of age), while no association was found between anxiety
and physical activity among participants of greater age
(≥ 52 years). In addition, results revealed a significant
interaction between anxiety, B = −.071; p = .034 and birth
country in predicting HbA1c. Among those born in the
U.S., greater anxiety was associated with higher HbA1c.Table 3 Associations between depression and indicators of g
(unstandardized coefficients [B] and standard errors [SE] are
Modi
BMI (N = 482) Waist cir
(cm;
B SE B
Age −.010 .026 .124*
Gender (Male = 1; Female = 2) .945 .715 −2.959
Education (years) −.029 .084 −.149
Assessment Language (1 = English; 2 = Spanish) −.493 1.241 −2.155
Birth Country (1 = U.S.; 2 = Mexico) −1.948* .859 −5.292*
Taking Diabetes Medication (0 = No; 1 = Yes) - - -
CES-D Score (depression) .058* .030 .159**
*p ≤ .05, **p ≤ .01, ***p ≤ .001.However, no association between anxiety and birth coun-
try was found among those born in Mexico.
Discussion
Overall, higher scores on measures of depression and
anxiety among Mexican Americans with diabetes were
associated with greater BMI and waist circumference,
and engaging in less physical activity. In addition, greater
depression was associated with higher fasting glucose,
while greater anxiety was associated with higher HbA1c.
Thus, the findings suggest that depression and anxietylycemic control among Mexican Americans with diabetes
presented)




(METs; N = 403)
Fasting glucose
(mg/dl; N = 486)
HbA1c
(N = 381)
SE B SE B SE B SE
.051 −17.791* 8.845 −.447** .167 −.033*** .010
1.683 −595.856 337.471 −20.512** 6.471 −.379 .256
.169 −2.894 26.881 .643 .591 −.009 .021
2.573 −53.315 411.599 −.996 9.120 −.333 .367
* 1.813 9.481 395.653 5.537 7.917 −.027 .283
- - - 45.387*** 5.942 .823** .270
.056 −20.543** 7.567 .646** .237 .017 .010
Table 4 Associations between anxiety and indicators of glycemic control among Mexican Americans with diabetes
(unstandardized coefficients [B] and standard errors [SE] are presented)
Modifiable factors Glycemic control indicators
BMI (N = 482) Waist circumference
(cm; N = 485)
Physical activity
(METs; N = 403)
Fasting glucose
(mg/dl; N = 486)
HbA1c
(N = 381)
B SE B SE B SE B SE B SE
Age −.015 .025 .114* .050 −19.124* 8.352 −.447** .169 −.033*** .010
Gender (Male = 1; Female = 2) .838 .701 −3.157 1.68 −672.833* 345.717 −19.798** 6.419 −.376 .248
Education (years) −.024 .082 −.144 .163 −.608 25.981 .571 .580 −.012 .021
Assessment Language(1 = English; 2 = Spanish) −.800 1.188 −2.944 2.45 50.556 404.397 −3.521 9.077 −.402 .367
Birth Country (1 = U.S.; 2 = Mexico) −1.990* .855 −5.401** 1.817 25.134 393.21 5.477 7.933 −.045 .283
Taking Diabetes Medication (0 = No; 1 = Yes) - - - - - - 45.133*** 6.059 .793** .263
SAS Score (Anxiety) .146*** .044 .336*** .090 −20.455* 10.308 .703 .389 .027* .014
*p ≤ .05, **p ≤ .01, ***p ≤ .001.
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ment of diabetes and glycemic control among Mexican
Americans residing near the U.S.- Mexico border.
Depressed/anxious participants differed from those who
were not depressed or anxious in a variety of ways. Similar
to nationally representative samples [50,51], depressed/
anxious Mexican Americans with diabetes were of greater
age, more likely to be female, and less educated than their
non-depressed/anxious counterparts; they also had greater
BMI and waist circumference, and engaged in less physical
activity. In contrast with other research focused on anxiety
disorder prevalence (e.g., [52]), anxious participants were
more likely than non-anxious participants to have been
born in Mexico than the U.S., and preferred to complete
study assessments in Spanish. Perhaps this finding may
be understood in the context of research indicating that
acculturative stress is associated with greater anxiety and
depression among Mexican Americans [53]. In addition,
Breslau et al. [54] found that immigration from Mexico
predicted the subsequent onset of anxiety. Plausibly, the
higher levels of anxiety among Mexican-born participants
may have been related to acculturative stress, though more
research will be needed to understand potential links
between nativity, acculturative stress, and anxiety.
Notably, age, years of education, assessment language,
and birth country each functioned as moderators of the
relationship between depression/anxiety with modifiable
factors and glycemic control. Specifically, anxiety was in-
versely associated with hours of physical activity among
younger participants, but not among participants ≥ 52 years
of age. Depression was positively associated with fasting
glucose among younger participants, while there was
no relation among older participants. Among younger
participants with diabetes, only 43% (vs. 71.2% among
older participants) had been told by a doctor that they
had diabetes and only 36.6% (vs. 63.8% among older
participants) were taking diabetes medication. Plaus-
ibly, depression may have had a greater impact onfasting glucose among those who were undiagnosed
and therefore not taking any medications to control
diabetes. Conversely, the fasting glucose of those taking
medications to control blood sugar may be less affected
by depression.
Interestingly, greater depression and anxiety were
associated with higher HbA1c among participants born
in the U.S., those who were more educated, and those
who completed the study assessments in English. Con-
versely, depression/anxiety was not associated with HbA1c
among those born in Mexico, those who were less edu-
cated, and those who completed the study assessments in
Spanish. Taken together, one interpretation of these find-
ings might be that glycemic control was more influenced
by depression among acculturated participants than those
who were less acculturated. In the current sample, those
born in the U.S. had greater education than those born in
Mexico (11.84 vs. 7.71 years) and similarly, those who
completed study assessments in English had greater edu-
cation than those who completed assessments in Spanish
(13.87 vs. 7.76 years on average). Perhaps more accul-
turated and educated participants had a better under-
standing of how to influence HbA1c through behavior,
as well as greater access to diabetes-related health care
(through greater education) than their less acculturated
and less educated counterparts. Vega et al. [55] reported
that acculturation was positively associated with cardio-
vascular disease-related health knowledge among Mexican
Americans, and that acculturation was strongly associated
with education. Thus, depression may have a greater nega-
tive impact on glycemic control among individuals who
are knowledgeable about diabetes care and have been ac-
tively managing their diabetes through behavior. Alterna-
tively, it is possible that depression may be associated with
dietary responses that differ by acculturation or education.
More research will be needed to understand the links
between nativity, language preference, education, and
glycemic control.
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anxiety, it seems plausible that the assessment and treat-
ment of depression and anxiety might improve self-
management of diabetes and glycemic control. However,
in a recent review it was concluded that while psycho-
social interventions may be effective for the treatment of
depression among individuals with diabetes, it is not clear
that such interventions have a beneficial impact on
diabetes-related outcomes [56]. Similarly, the findings of
initial research suggest that pharmacological treatments
for depression improve mood, but have little impact on
glycemic control (for a review, see [34]). Additional studies
are needed to evaluate the impact of more comprehensive
interventions designed to target both depression and dia-
betes management, and to identify other factors that are
related to both mood and glycemic control. For example,
recent research suggests that depression is associated with
increased risk for the onset of dementia in individuals with
diabetes [57]. Finally, treatments designed to increase
physical activity may be particularly beneficial for the dual
purpose of reducing depression and improving glycemic
control [58].
The current study has several strengths and limitations.
A notable strength of the study was the sample comprised
entirely of Mexican Americans with diabetes who were
recruited from within the community of Brownsville,
TX (on the U.S.-Mexico border), thereby avoiding the
bias inherent in clinic-based studies. Latinos/Hispanics
are a vulnerable and understudied group as it relates to
diabetes, and even less attention has been paid to the
health of those living along the border. A limitation of
the study was the cross-sectional design. As such, we
were not able to determine whether there might be a
causal relation between depression, modifiable behav-
ioral factors, and glycemic control among Mexican
Americans with diabetes. Similarly, we could not deter-
mine whether depression precedes or develops subse-
quent to poor glycemic control. Plausibly, modifiable
factors, such as BMI and waist circumference, may me-
diate the relations between depression and glycemic
control among Mexican Americans as in other samples
(e.g., [59]). However, given the cross-sectional nature of
the data these mediational relationships were not evalu-
ated. Finally, it is notable that the physical activity
measure (from which METS were calculated) changed
during the course of the study (i.e., IPAQ to Godin) and
some participants completed the physical activity as-
sessment after a delay (i.e., assessment not completed
concurrently with other measures) which may have
impacted the findings. However, please note that de-
pression and anxiety remained significantly related to
physical activity (METs) even after controlling for the
specific physical activity measure (Godin vs. IPAQ vs.
delayed assessment).Conclusions
Greater depression and anxiety were associated with
poorer behavioral management of diabetes management
and poorer glycemic control among Mexican Americans
living near the U.S.-Mexico border. Findings highlight
the need for comprehensive interventions designed to
target depression and anxiety in the context of diabetes
management among border residents. Understanding the
psychosocial and behavioral factors associated with dia-
betes management among Latinos/Hispanics is a first
step towards reducing and eliminating diabetes-related
health disparities.
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